Skip to main content
Erschienen in: AIDS and Behavior 1/2013

01.01.2013 | Original Paper

Injection Drug Use and HIV Antiretroviral Therapy Discontinuation in A Canadian Setting

verfasst von: Dan Werb, M.-J. Milloy, Thomas Kerr, Ruth Zhang, Julio Montaner, Evan Wood

Erschienen in: AIDS and Behavior | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

We investigated whether drug-related behaviors predicted antiretroviral therapy (ART) discontinuation among a cohort of injection drug users (IDU) in a Canadian setting. Cox regression analyses were used to investigate the impact of drug use patterns on rates of ART discontinuation among a sample of HIV-positive IDU in Vancouver, Canada between May 1996 and April 2008. In total, 408 HIV-positive IDU initiated ART during the study period, among whom 257 (63.0%) discontinued ART at least once. Rates of ART discontinuation were not significantly elevated among those who reported ongoing injection of heroin, cocaine, or other illicit drugs in comparison to those who reported not injecting drugs. However, public drug use was significantly predictive of ART discontinuation. Our findings may contribute to a reconsideration of the role of active drug use in determining retention in ART programs among IDU.
Literatur
1.
Zurück zum Zitat Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372(9651):1733–45.PubMedCrossRef Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372(9651):1733–45.PubMedCrossRef
2.
Zurück zum Zitat Wolfe D, Malinowska-Sempruch K. Illicit drug policies and the global HIV epidemic: effects of UN and national government approaches. Report. New York: Open Society Institute; 2004. Wolfe D, Malinowska-Sempruch K. Illicit drug policies and the global HIV epidemic: effects of UN and national government approaches. Report. New York: Open Society Institute; 2004.
3.
Zurück zum Zitat UNAIDS. Report on the global AIDS epidemic. Geneva: Joint United Nations Programme on HIV/AIDS; 2008. p. 2008. UNAIDS. Report on the global AIDS epidemic. Geneva: Joint United Nations Programme on HIV/AIDS; 2008. p. 2008.
4.
Zurück zum Zitat Donoghoe M, Verster AD, Mathers B. WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. Geneva: WHO/UNODC/UNAIDS; 2009. Donoghoe M, Verster AD, Mathers B. WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. Geneva: WHO/UNODC/UNAIDS; 2009.
5.
Zurück zum Zitat Dewhurst J. HIV Preventing infection among injecting drug users in high-risk countries: an assessment of the evidence. AIDS Care. 2010;22(3):397.CrossRef Dewhurst J. HIV Preventing infection among injecting drug users in high-risk countries: an assessment of the evidence. AIDS Care. 2010;22(3):397.CrossRef
6.
Zurück zum Zitat Ball A, Beg M, Doupe A, Weiler G. Evidence for action: a critical tool for guiding policies and programmes for HIV prevention, treatment and care among injecting drug users. Int J Drug Pol. 2005;16(1):1–6.CrossRef Ball A, Beg M, Doupe A, Weiler G. Evidence for action: a critical tool for guiding policies and programmes for HIV prevention, treatment and care among injecting drug users. Int J Drug Pol. 2005;16(1):1–6.CrossRef
7.
Zurück zum Zitat Volkow ND, Montaner J. Enhanced HIV testing, treatment, and support for HIV-infected substance users. JAMA. 2010;303(14):1423.PubMedCrossRef Volkow ND, Montaner J. Enhanced HIV testing, treatment, and support for HIV-infected substance users. JAMA. 2010;303(14):1423.PubMedCrossRef
8.
Zurück zum Zitat Hayden EC. ‘Seek, test and treat’ slows HIV. Nature. 2010;463:1006.CrossRef Hayden EC. ‘Seek, test and treat’ slows HIV. Nature. 2010;463:1006.CrossRef
9.
Zurück zum Zitat Oka S. Treatment 2.0 Fact Sheet. Geneva: UNAIDS, 2010. Oka S. Treatment 2.0 Fact Sheet. Geneva: UNAIDS, 2010.
10.
Zurück zum Zitat Jha CK, Madison J. Disparity in health care: HIV, stigma, and marginalization in Nepal. J Int AIDS Soc. 2009;12:16.PubMedCrossRef Jha CK, Madison J. Disparity in health care: HIV, stigma, and marginalization in Nepal. J Int AIDS Soc. 2009;12:16.PubMedCrossRef
11.
Zurück zum Zitat Vervoort SCJM, Borleffs JCC, Hoepelman AIM, Grypdonck MHF. Adherence in antiretroviral therapy: a review of qualitative studies. AIDS. 2007;21(3):271.PubMedCrossRef Vervoort SCJM, Borleffs JCC, Hoepelman AIM, Grypdonck MHF. Adherence in antiretroviral therapy: a review of qualitative studies. AIDS. 2007;21(3):271.PubMedCrossRef
12.
Zurück zum Zitat Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006;3(11):e438.PubMedCrossRef Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006;3(11):e438.PubMedCrossRef
13.
Zurück zum Zitat Malta M, Strathdee S, Magnanini MMF, Bastos FI. Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review. Addiction. 2008;103(8):1242–57.PubMedCrossRef Malta M, Strathdee S, Magnanini MMF, Bastos FI. Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review. Addiction. 2008;103(8):1242–57.PubMedCrossRef
14.
Zurück zum Zitat Wood E, Kerr T, Tyndall MW, Montaner JSG. A review of barriers and facilitators of HIV treatment among injection drug users. AIDS. 2008;22(11):9.CrossRef Wood E, Kerr T, Tyndall MW, Montaner JSG. A review of barriers and facilitators of HIV treatment among injection drug users. AIDS. 2008;22(11):9.CrossRef
15.
Zurück zum Zitat Friedland GH, Williams A. Attaining higher goals in HIV treatment: the central importance of adherence. AIDS. 1999;13(1):S61–72.PubMed Friedland GH, Williams A. Attaining higher goals in HIV treatment: the central importance of adherence. AIDS. 1999;13(1):S61–72.PubMed
16.
Zurück zum Zitat Palepu A, Tyndall MW, Joy R, Kerr T, Wood E, Press N, et al. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alc Depend. 2006;84(2):188–94.CrossRef Palepu A, Tyndall MW, Joy R, Kerr T, Wood E, Press N, et al. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alc Depend. 2006;84(2):188–94.CrossRef
17.
Zurück zum Zitat Strathdee SA, Palepu A, Cornelisse PG, Yip B, O’Shaughnessy MV, Montaner JS, et al. Barriers to use of free antiretroviral therapy in injection drug users. JAMA. 1998;280(6):547.PubMedCrossRef Strathdee SA, Palepu A, Cornelisse PG, Yip B, O’Shaughnessy MV, Montaner JS, et al. Barriers to use of free antiretroviral therapy in injection drug users. JAMA. 1998;280(6):547.PubMedCrossRef
18.
Zurück zum Zitat Wood E, Hogg RS, Bonner S, Kerr T, Li K, Palepu A, et al. Staging for antiretroviral therapy among HIV-infected drug users. JAMA. 2004;292(10):1175.PubMedCrossRef Wood E, Hogg RS, Bonner S, Kerr T, Li K, Palepu A, et al. Staging for antiretroviral therapy among HIV-infected drug users. JAMA. 2004;292(10):1175.PubMedCrossRef
19.
Zurück zum Zitat Kerr T, Palepu A, Barness G, Walsh J, Hogg R, Montaner J, et al. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver. Antivir Ther. 2004;9(3):407.PubMed Kerr T, Palepu A, Barness G, Walsh J, Hogg R, Montaner J, et al. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver. Antivir Ther. 2004;9(3):407.PubMed
20.
Zurück zum Zitat Kerr T, Marshall A, Walsh J, Palepu A, Tyndall M, Montaner J, et al. Determinants of HAART discontinuation among injection drug users. AIDS Care. 2005;17(5):539.PubMedCrossRef Kerr T, Marshall A, Walsh J, Palepu A, Tyndall M, Montaner J, et al. Determinants of HAART discontinuation among injection drug users. AIDS Care. 2005;17(5):539.PubMedCrossRef
21.
Zurück zum Zitat Twisk JWR, Smidt N, de Vente W. Applied analysis of recurrent events: a practical overview. J Epidemiol Community Health. 2005;59(8):706.PubMedCrossRef Twisk JWR, Smidt N, de Vente W. Applied analysis of recurrent events: a practical overview. J Epidemiol Community Health. 2005;59(8):706.PubMedCrossRef
22.
Zurück zum Zitat Wood E, Hogg RS, Yip B, Harrigan PR, O’Shaughnessy MV, Montaner JS. Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy? AIDS. 2003;17(5):711.PubMedCrossRef Wood E, Hogg RS, Yip B, Harrigan PR, O’Shaughnessy MV, Montaner JS. Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy? AIDS. 2003;17(5):711.PubMedCrossRef
23.
Zurück zum Zitat Werb D, Mills EJ, Montaner JSG, Wood E. Risk of resistance to highly active antiretroviral therapy among HIV-positive injecting drug users: a meta-analysis. Lancet Inf Dis. 2010;10(7):464–9.CrossRef Werb D, Mills EJ, Montaner JSG, Wood E. Risk of resistance to highly active antiretroviral therapy among HIV-positive injecting drug users: a meta-analysis. Lancet Inf Dis. 2010;10(7):464–9.CrossRef
24.
Zurück zum Zitat WHO. WHO, HIV/AIDS treatment and care for injecting drug users: Clinical protocol for the WHO European region. WHO Regional Office for Europe: Copenhagen; 2006. WHO. WHO, HIV/AIDS treatment and care for injecting drug users: Clinical protocol for the WHO European region. WHO Regional Office for Europe: Copenhagen; 2006.
25.
Zurück zum Zitat Department of Health and Human Services. Panel on antiretroviral guidelines for adults and adolescents: Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Washington: Department of Health and Human Services; 2008. Department of Health and Human Services. Panel on antiretroviral guidelines for adults and adolescents: Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Washington: Department of Health and Human Services; 2008.
26.
Zurück zum Zitat Altice FL, Bruce RD, Lucas GM, Lum PJ, Korthuis PT, Flanigan TP, et al. HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study. JAIDS. 2011;56:S22.PubMedCrossRef Altice FL, Bruce RD, Lucas GM, Lum PJ, Korthuis PT, Flanigan TP, et al. HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study. JAIDS. 2011;56:S22.PubMedCrossRef
27.
Zurück zum Zitat Stevens LM. Cocaine addiction. JAMA. 2002;287(1):1. Stevens LM. Cocaine addiction. JAMA. 2002;287(1):1.
28.
Zurück zum Zitat DeBeck K, Small W, Wood E, Li K, Montaner J, Kerr T. Public injecting among a cohort of injecting drug users in Vancouver Canada. J Epidemiol Community Health. 2009;63(1):81–6.PubMedCrossRef DeBeck K, Small W, Wood E, Li K, Montaner J, Kerr T. Public injecting among a cohort of injecting drug users in Vancouver Canada. J Epidemiol Community Health. 2009;63(1):81–6.PubMedCrossRef
29.
Zurück zum Zitat Rhodes T, Kimber J, Small W, Fitzgerald J, Kerr T, Hickman M, et al. Public injecting and the need for “safer environment interventions” in the reduction of drug-related harm. Addiction. 2006;101(10):1384.PubMedCrossRef Rhodes T, Kimber J, Small W, Fitzgerald J, Kerr T, Hickman M, et al. Public injecting and the need for “safer environment interventions” in the reduction of drug-related harm. Addiction. 2006;101(10):1384.PubMedCrossRef
30.
Zurück zum Zitat Small W, Rhodes T, Wood E, Kerr T. Public injection settings in Vancouver: physical environment, social context and risk. Int J Drug Pol. 2007;18(1):27–36.CrossRef Small W, Rhodes T, Wood E, Kerr T. Public injection settings in Vancouver: physical environment, social context and risk. Int J Drug Pol. 2007;18(1):27–36.CrossRef
31.
Zurück zum Zitat Hickman M, Hope V, Brady T, Madden P, Jones S, Honor S, et al. Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004. J Viral Hepatitis. 2007;14(9):645–52.CrossRef Hickman M, Hope V, Brady T, Madden P, Jones S, Honor S, et al. Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004. J Viral Hepatitis. 2007;14(9):645–52.CrossRef
32.
Zurück zum Zitat Hope V, Kimber J, Vickerman P, Hickman M, Ncube F. Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England. BMC Infect Dis. 2008;8(1):120.PubMedCrossRef Hope V, Kimber J, Vickerman P, Hickman M, Ncube F. Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England. BMC Infect Dis. 2008;8(1):120.PubMedCrossRef
33.
Zurück zum Zitat Topp L, Iversen J, Conroy A, Salmon AM, Maher L. Prevalence and predictors of injecting related injury and disease among clients of Australia’s needle and syringe programs. Aust N Z J Public Health. 2008;32(1):34–7.PubMedCrossRef Topp L, Iversen J, Conroy A, Salmon AM, Maher L. Prevalence and predictors of injecting related injury and disease among clients of Australia’s needle and syringe programs. Aust N Z J Public Health. 2008;32(1):34–7.PubMedCrossRef
34.
Zurück zum Zitat Small W, Kerr T, Charette J, Schechter M, Spittal PM. Impacts of intensified police activity on injection drug users: Evidence from an ethnographic investigation. Int J Drug Pol. 2006;17(2):85.CrossRef Small W, Kerr T, Charette J, Schechter M, Spittal PM. Impacts of intensified police activity on injection drug users: Evidence from an ethnographic investigation. Int J Drug Pol. 2006;17(2):85.CrossRef
35.
Zurück zum Zitat Lloyd-Smith E, Rachlis BS, Tobin D, Stone D, Li K, Small W, et al. Assisted injection in outdoor venues: an observational study of risks and implications for service delivery and harm reduction programming. Harm Reduct J. 2010;7(1):6.PubMedCrossRef Lloyd-Smith E, Rachlis BS, Tobin D, Stone D, Li K, Small W, et al. Assisted injection in outdoor venues: an observational study of risks and implications for service delivery and harm reduction programming. Harm Reduct J. 2010;7(1):6.PubMedCrossRef
Metadaten
Titel
Injection Drug Use and HIV Antiretroviral Therapy Discontinuation in A Canadian Setting
verfasst von
Dan Werb
M.-J. Milloy
Thomas Kerr
Ruth Zhang
Julio Montaner
Evan Wood
Publikationsdatum
01.01.2013
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 1/2013
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-012-0136-y

Weitere Artikel der Ausgabe 1/2013

AIDS and Behavior 1/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.